Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7101 USD | -4.04% | -8.96% | -77.82% |
May. 22 | Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy | MT |
May. 15 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
Chart calendar Virpax Pharmaceuticals, Inc.
Upcoming events on Virpax Pharmaceuticals, Inc.
Past events on Virpax Pharmaceuticals, Inc.
2024-05-13 04:10 pm | Q1 2024 Earnings Release |
2024-03-26 07:30 am | Q4 2023 Earnings Release |
2023-12-27 | Extraordinary Shareholders Meeting |
2023-11-15 04:15 pm | Q3 2023 Earnings Release |
2023-10-03 03:00 pm | LD Micro Main Event Conference |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-14 09:00 am | Q2 2023 Earnings Release |
2023-07-24 10:30 am | Annual General Meeting |
2023-06-20 01:00 pm | Maxim Group Virtual Healthcare Conference |
2023-06-07 | CB Tech Watch Seminar |
2023-05-12 04:08 pm | Q1 2023 Earnings Release |
2023-05-11 10:45 am | Sidoti Micro-Cap Virtual Conference |
2023-03-22 08:58 am | Q4 2022 Earnings Release |
2022-11-09 09:00 am | Q3 2022 Earnings Release |
2022-08-15 09:00 am | Interim 2022 Earnings Release |
2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
2022-05-16 09:00 am | Q1 2022 Earnings Release |
2022-03-31 09:00 am | FY 2021 Earnings Release |
2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
2021-11-15 08:00 am | Q3 2021 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -12,0 -11,9 -1.02% | -21,8 -26,6 17.76% | -15,7 -14,5 -8.19% | -12,7 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -21,7 -26,5 18.25% | -15,2 -14,1 -7.54% | -12,6 |
Net income Million USD | Released Forecast Spread | -4,34 | 0,00 0,00 - | -21,7 -26,5 18.25% | -15,2 -14,1 -7.54% | -12,6 |
EPS USD | Released Forecast Spread | -14,0 | 0,00 0,00 - | -18,5 -22,6 18.14% | -13,0 -12,0 -8.08% | -5,68 |
Announcement Date | 31/03/21 | 31/03/22 | 22/03/23 | 26/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -5,90 -5,19 -13.69% | -7,72 -5,99 -28.8% | -3,10 -7,82 60.33% | -1,65 -3,48 52.56% | -3,24 -1,88 -72.5% | -4,68 -3,50 -33.98% | -3,08 | -3,12 | -3,17 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,88 -5,19 -13.32% | -7,64 -5,99 -27.58% | -2,99 -7,82 61.8% | -1,52 -3,48 56.31% | -3,11 -1,88 -65.75% | -4,56 -3,50 -30.48% | -3,08 | -3,12 | -3,17 | ||
Net income Million USD | Released Forecast Spread | -5,14 | -5,88 -5,19 -13.32% | -7,64 -5,99 -27.58% | -2,99 -7,82 61.8% | -1,52 -3,48 56.31% | -3,11 -1,88 -65.75% | -4,56 -3,50 -30.48% | -3,08 | -3,12 | -3,17 | |
EPS USD | Released Forecast Spread | -4,40 | -5,00 -4,40 -13.64% | -6,50 -5,10 -27.45% | -2,60 -6,70 61.19% | -1,30 -3,00 56.67% | -2,70 -1,60 -68.75% | -12,1 -3,00 -302% | -1,53 | -1,10 | -1,11 | |
Announcement Date | 16/05/22 | 15/08/22 | 09/11/22 | 22/03/23 | 12/05/23 | 14/08/23 | 26/12/23 | 26/03/24 | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Virpax Pharmaceuticals, Inc.
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VRPX Stock
- Calendar Virpax Pharmaceuticals, Inc.